Vascular Medicine Institute
University of Pittsburgh
BST E1240
200 Lothrop Street
Pittsburgh, PA 15261
Phone: 412-383-5853
Fax: 412-648-5980

News Archive

VMI YouTube VMI Twitter
  Back to Recent News

January 19, 2015 - A New Way to Model Sickle Cell Behavior

Dr. Greg Kato is part of a team, led by CMU President Subra Suresh, that recently developed a new way to model sickle cell behavior. READ MORE...


October 2014 - Children's Sickle Cell Foundation visits VMI

We were honored to have the Children’s Sickle Cell Foundation, local sickle cell patients, and other partners tour research laboratories as part of the Living Well with Sickle Cell® Family Research Summit.


June 10, 2014 - VMI/HVI Innovator Awards

Drs. Mark Gladwin and Joon Lee are pleased to announce the funding of the first three Innovator Awards featuring collaborations between VMI and HVI faculty members. The projects represent cutting-edge science and highlight how the synergy between VMI and HVI faculty will open new and exciting areas of research.

Congratulations to the first round awardees!*

Four more awards were announced in August and October 2014.
See the VMI/HVI Innovator Awards page for more information.


May 2014 - VMI Faculty key contributors to ATS Clinical Practice Guideline

VMI faculty contributed a major leadership role to the recent American Thoracic Society (ATS) clinical practice guideline on the Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension in Sickle Cell Disease. The guideline has been created to reduce the variability and improve quality of care in patients with Sickle Cell Disease (SCD). The guideline will provide a consensus resource for hematologists, pulmonologists, cardiologists, pediatrician, cardiologists, pediatricians, and internists to help with management of SCD patients. The guidelines have already received the endorsement of the ATS, the American College of Chest Physicians, and the Pulmonary Hypertension Association. VMI Director, Dr Mark Gladwin, an internationally recognized leader in the field of SCD comments "10% of adult patients with sickle cell disease develop pulmonary hypertension and these patients suffer a 10-fold increase in their risk of death compared with sickle cell patients without pulmonary hypertension. These new guildlines provide clear direction on risk assessments using Doppler-echocardiography, laboratory N-terminal pro-BNP screening, and indications for right heart catheterization, as well as clear expert- and evidence-based recommendations for therapy.” Drs. Greg Kato, Lakshamanan Krishnamurti, and Mark Gladwin were major contributors to the formation of this landmark document.


September 2013 - Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute

Dr. Mark Gladwin was named Director of the newly formed Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute (VMI), and Program Director of the UPMC Heart and Vascular Insitute (HVI).

Listen to Dr. Gladwin and Dr. Joon Lee to learn more about it here:


September 4, 2012 - Launch of Ryan Clark's Cure League - Tackling Sickle Cell!

Ryan Clark's Cure League, conceived by Pittsburgh Steelers' safety and leading tackler Ryan Clark, raises money for sickle cell disease research, clinical care, and increased awareness about this painful, life-threatening disease. Dedicated researchers and medical professionals at the University of Pittsburgh’s Vascular Medicine Institute and UPMC need your help and resources to make a difference and end the suffering caused by sickle cell disease.

For more information, please visit the Cure League Website and Twitter feed.
Click HERE to watch the press conference and read the press release.

LEFT: Dr. Mark Gladwin listens as Ryan Clark talks about the Cure League initiative.
(Photo by Lake Fong/ Pittsburgh Post-Gazette)
Cure League


July 23, 2012 - Dr. Gladwin on the Discovery Channel

Dr. Gladwin discusses "Managing Pulmonary Hypertension in Sickle Cell Patients".



March 30, 2012 - Visit by Pittsburgh Steelers' Safety Ryan Clark

Ryan Clark, of the Pittsburgh Steelers, visited the VMI to learn more about Sickle Cell research.

Ryan Clark visits the VMI


March 29, 2012 - Members of British Parliament Tour the VMI

The VMI was honored to be visited by Members of the Specialist Delegation of the British-American Parliamentary Group, including Christopher Pincher, Angela Smith, and Derek Twigg (all members of Parliament); The Right Honorable Lord David Trimble; Matthew Windrum, Vice Consul (Politics), British Consulate-General (New York); and Bradley Keelor, Senior Science and Innovation Policy Officer (Wash DC). The group is examining the U.S. and regional economy, including the impact of the American Recovery and Reinvestment Act, funds from which were used to build our new laboratories.

Dr. Gladwin demonstrates how to use the NOA. Lord Trimble views zebrafish in the microscope.
Dr. Gladwin explains how the Nitric Oxide Analyzer (NOA) measures nitric oxide levels in sinuses. Dr. Paola Corti describes the VMI's work with zebrafish to Lord Trimble, as he looks at samples.


March 19, 2012 - Dedication of Plaque to honor David Buchanan

On Monday, March 19, the VMI welcomed employees from McKamish, Inc. The purpose of their visit was to unveil a plaque in honor of their friend and co-worker, David “Buck” Buchanan, who was a project manager for McKamish and whose final project was the VMI laboratories.  Mr. Buchanan died suddenly from a cerebral aneurysm in October, just as the labs were being finished. In December, McKamish, Inc. made a very generous gift to the VMI, in memory of Mr. Buchanan, to support cerebral vascular research.

McKamish Gift


November 18, 2011 - Inauguration of the VMI's new space

On November 18, 2011, the VMI celebrated the inauguration of its new "home" on the 12th floor of the Thomas E. Starzl Biomedical Science Tower.


November 18, 2011 - Up to $15 Million Committed for Continued Funding of the VMI

News release from the University of Pittsburgh: "The Vascular Medicine Institute (VMI) of the University of Pittsburgh School of Medicine today received a new commitment of up to $7.5 million from the Blood Science Foundation and the Institute for Transfusion Medicine (ITxM), as well as an additional commitment of up to $7.5 million in a phased, five-year renewal from The Hemophilia Center of Western Pennsylvania (HCWP). ..."


October 21, 2011 - The VMI moves to its new location

To accommodate our expanding Institute, the Dean received a $15 million C06 grant from the NIH to renovate the 12th floor of the Thomas E. Starzl Biomedical Science Tower.  This new space encompasses a total of 21,000 square feet and fosters an open laboratory collaboration.  The Institute moved from its former, temporary location in BST3 on October 21, 2011.